|
G2C uses genome information as part of a general strategy
for understanding cognition at the molecular, cellular and systems
neuroscience levels. We use a multi-disciplinary
approach to psychiatric diseases including learning impairment, cognitive decline with
ageing, dementias, schizophrenia and related psychoses, and brain
injury.
We aim to :
- understand normal cognitive function at a new level of detail;
- find the basis of neurodegenerative diseases;
- generate valuable genetic resources for animal and human research;
- create, and make publicly available, novel databases for basic and clinical
neuroscience; and
- establish a general model for tackling diseases and brain function.
Our integrative approach should help to
bring together the disciplines of psychiatric genetics
(which has yet to identify genes for major psychiatric disorders)
and animal behavioural psychology (which does
not yet exploit the great strides made in understanding human
cognitive psychology).
G2C in Depth: An Integrative Neuroscience Program Linking Mouse Genes to Cognition and Disease
Follow these links for a detailed description of the G2C programme and its organization.
|